Allogeneic #CARTCells in phase Ib/II clinical trials in China for the treatment of relapsed/refractory multiple myeloma (R/R MM) and primary plasma cell leukemia (pPCL). Phase I study showed interesting results. buff.ly/SKuRXC9

"There’s a good likelihood that by 2050, all scientific research will be done by superintelligent AI rather than human researchers,” Bostrom said in an e-mail. “Some humans might do science as a hobby, but they wouldn’t be making any useful contributions.” The science of 2025 buff.ly/nElWVRL

Monkey pluripotent stem cells-derived blastoids mature in vitro in 3D into Carnegie stage 8-9 (late gastrulation) embryos. Spectacular progress to study primate embryonic development. buff.ly/IiFHeNU

A phase II trial using #CART cells against a solid tumor (glioblastoma). T-MAXIMUM Pharmaceutical announced that its proprietary allogeneic B7-H3–targeted CAR-T therapy, MT027, has received FDA IND clearance. buff.ly/wiGPeyR

Modeling human embryo implantation in vitro: building a receptive endometrium and its interaction with blastoids (“synthetic embryos”). A remarkable achievement! buff.ly/eZtS5NG

Kyverna to take autoimmune CAR-T to FDA after success in stiff person syndrome trial. #CARTCells #Autoimmune disease

Le samedi soir, il est réjouissant – voire emballant – de poster du Tom Gauld www.tomgauld.com (description et traduction en cliquant sur ALT).

Holy crap!!

Venez découvrir en ce mois de décembre la serre à cactées du Jardin des Plantes de MONTPELLIER. Attention, vous devez vous inscrire pour y participer.

En ce mois de décembre, laissez vous guider par la magie du Jardin des Plantes de Montpellier : un écrin de nature à découvrir au fil de nos visites....

Early in vivo #CART results like Kelonia's elicit excitement across the field. buff.ly/70ZzqzS

Allogeneic anti-CD7 #CARTCells for relapsing T-ALL eradication prior to hematopoietic allograft! Universal Base-Edited CAR7 T Cells for T-Cell Acute Lymphoblastic Leukemia | New England Journal of Medicine buff.ly/7jYX07o

On découvre que l'immunité existe depuis les bactéries. Elle pourrait amener à redéfinir ce qu’est un être vivant, puisqu'elle distingue de manière universelle le soi du non-soi. Très bel article dans @lemonde.fr www.lemonde.fr/sciences/art...

Every single person working today in every branch of cell and gene therapy - viral, nonviral, editing, transgenesis - owes a deep debt of gratitude to Dr. High.

Our meeting has now come to a close. Many thanks to all attendees and our outstanding speakers. See you in Paris in 2027! #FSSCR2025 Lyon, Nov 17–19, 2025

The FSSCR Best Short Talk and Best Poster prizes — sponsored by the Fondation Marion & Elisabeth Brancher and Development — were awarded by Anne Camus and @crougeulle.bsky.social. Bravo to the winners! #FSSCR2025 Lyon, Nov 17–19, 2025

new paper by Sean Westwood: With current technology, it is impossible to tell whether survey respondents are real or bots. Among other things, makes it easy for bad actors to manipulate outcomes. No good news here for the future of online-based survey research

Such a treat to be sitting in the room where @denisduboule.bsky.social is giving a talk @fsscr.bsky.social meeting in Lyon! Exciting and insightful science ahead 🤯🤘

🙏🏼 A wonderful meeting indeed. Full of great science and energy 👏 @fsscr.bsky.social

Today, #FSSCR is tuning in to pluripotent stem cells… and their mechanical properties in plants! 🌱🔬 Who said curiosity has boundaries? Pradeep Das (ENS Lyon) presenting. #FSSCR2025 Lyon, Nov 17–19, 2025 coms.events/fsscr25/inde...

En route to Lyon, capital of French gastronomy 🍽️🍷, and stem cell research🔬🧫🧬(for this week)! Very excited to participate to the 7th #FSSCR Meeting and present our most recent work on spatial #mechanomics! Thank you @bardinlab.bsky.social @jdevos.bsky.social & to all organisers for the invitation!

Fantastic conference! Learning a lot about stem cells, organoids and everything in this fascinating world! Thanks a lot to the organizers for inviting me!

Agathe Coeur presenting her work on improving NKX2.1+ lung progenitors production using a design of experiment (DOE) approach, at the FSSCR meeting. Thumbs up! #FSSCR2025 ✨🔬 Exciting #StemCell science ahead! Lyon, Nov 17–19, 2025 Full program here 🫵 buff.ly/kLeH5ET

Nancy Mah (X : @NancyScience ) presenting the past and current pluripotent stem cell clinical trials worldwide. Clinical applications are coming! #FSSCR2025 ✨🔬 Exciting #StemCell science ahead! Lyon, Nov 17–19, 2025 Full program here 🫵 buff.ly/kLeH5ET

The second day of the #FSSCR2025 meeting is starting by an exciting presentation on adult neurogenesis in vertebrates by @zaycha.bsky.social. ✨ #StemCell science Lyon, Nov 17–19, 2025 🫵 coms.events/fsscr25/inde...

@karinayaniv.bsky.social share her work on the lymphatic lineage and cell fate (completely underestimated cell type), using zebrafish models but also ESC. Very beautiful work. #FSSCR2025 ✨ Exciting #StemCell science ahead! Lyon, Nov 17–19, 2025 🫵 coms.events/fsscr25/inde...

Pierre Savatier discussing his recent results on inter-species chimeras, including those based on rabbit blastocysts, and based on primate (human and non-human) naive #iPSCells. #FSSCR2025 ✨🔬 Exciting #StemCell science ahead! Lyon, Nov 17–19, 2025 Full program here 🫵 buff.ly/kLeH5ET

@hansclevers.bsky.social with full creativity at #FSSCR2025! Thanks to him to share his research with the audience. #FSSCR2025 ✨🔬 Exciting #StemCell science ahead! Lyon, Nov 17–19, 2025 Full program here 🫵 buff.ly/kLeH5ET

The 7th #FSSCR Annual Meeting is starting today! Welcome to all of you. ✨🔬 Exciting #StemCell science ahead! Lyon, Nov 17–19, 2025 Full program here 🫵 buff.ly/kLeH5ET

The iPSC platform session now! Lead by Laurent David 🙏 The 7th #FSSCR Annual Meeting is starting today! ✨🔬 Exciting #StemCell science ahead! Lyon, Nov 17–19, 2025 #FSSCR2025 😍 Full program here 🫵 buff.ly/I7w5Vyy

The 7th #FSSCR Annual Meeting is starting today! Welcome to all of you. ✨🔬 Exciting #StemCell science ahead! Lyon, Nov 17–19, 2025 Use the hashtag #FSSCR2025 😍 Full program here 🫵 coms.events/fsscr25/en/d...

You and the text you need to trim in order to meet the word limit

✨🔬 Get ready for groundbreaking #StemCell research! Join us in Lyon, Nov 17–19, 2025, for the 7th #FSSCR Annual Meeting. Connect with leading experts and be part of inspiring scientific exchanges 👇 👉 buff.ly/FRotkAi @FSSCR_officiel #FSSCR2025

✨🔬 Exciting #StemCell science ahead! Join us in Lyon, Nov 17–19, 2025 for the 7th #FSSCR Annual Meeting. Meet top speakers and take part in inspiring discussions 👇 👉 buff.ly/FRotkAi @FSSCR_officiel #FSSCR2025

Jennifer Doudna startup launches with $82M to apply new #CRISPR delivery technology to in vivo #CARTCells. buff.ly/mewzZFL

Happy Halloween

✨🔬 Get ready for groundbreaking #StemCell research! Join us in Lyon, Nov 17–19, 2025, for the 7th #FSSCR Annual Meeting. Connect with leading experts and be part of inspiring scientific exchanges 👇 👉 buff.ly/FRotkAi @FSSCR_officiel #FSSCR2025

#iPSC-derived, off-the-shelf anti-CD19 #CARTcells deliver improved clinical outcomes in lupus. buff.ly/h2uH87G

✨🔬 Exciting #StemCell science ahead! Join us in Lyon, Nov 17–19, 2025 for the 7th #FSSCR Annual Meeting. Meet top speakers and take part in inspiring discussions 👇 👉 buff.ly/FRotkAi @FSSCR_officiel #FSSCR2025

Le samedi soir, malgré tout, il est pertinent – voire évident – de poster du Tom Gauld. www.tomgauld.com (description et traduction en cliquant sur ALT).

Une analyse équilibrée, pertinente et solidement argumentée sur la place de l’IA dans l’enseignement supérieur. Une lecture incontournable. (Les militaires ont plein de choses à nous apprendre!)

✨🔬Great #StemCell research. Come, discuss, join us in Lyon Nov 17-19, 2025 at the 7th #FSSCR annual meeting. Outstanding talks, see speakers: 👉https://buff.ly/FRotkAi 📆 Regular rates available until 19 Oct 2025 @FSSCR_officiel #FSSCR2025

As I sit during a break in my conference at Harvard Medical School, this news really fucking sucks😞

Galapagos exits the cell therapy field, joining other recent high-profile departures such as Novo Nordisk and Takeda. Tough times for the sector. buff.ly/x1igaTU

Anti-BCMA #CARTells therapy in patients with progressive multiple sclerosis. Encouraging phase I study in 5 patients. via @CellCellPress buff.ly/tK6QG6D

BIG ANNOUNCEMENT📣: I haven’t been this excited to be part of something new in 15 years… Thrilled to reveal the passion project I’ve been working on for the past year and a half!🙀🥳 (thread 👇)

Novo Withdraws from $598M Heartseed Partnership; Pursues Short-Term Profit Over #iPSC Potential. buff.ly/fJOpc4R

Danièle Noël from the IRMB Institute (Montpellier) share her works on MSC-derived EVs. Great work! #ITD2025

Sjoukje van der Stegen, from the Chan Zuckerberg Biohub New York share her works on iPS-derived #CARTCells. #ITD2025

Happy to participate and proud to contribute to this fifth Innovative Therapies Days (ITD) 2025 conference in Besançon. Great science, biotech and networking! #ITD2025